Title: Outcome of Hypo Fractionated Radiotherapy in Early Breast Cancer
Authors: Dr Ajithkumar V R, Dr Jayakumar K L, Dr Ansa T J, Dr Shehna A Khader
DOI: https://dx.doi.org/10.18535/jmscr/v7i10.107
Abstract
Introduction: The standard radiotherapy fractionation in breast cancers practised in worldwide is 50Gy in 25 fractions. Some trials have tested the hypothesis that breast cancer is as sensitive to fraction size as the normal tissues of the breast and underlying rib cage and that a more effective strategy would be to deliver fewer, larger fractions to a lower total dose regimens (hypofractionation). The purpose of this study is to assess the tissue toxicity, quality of life and local recurrence of patients undergoing hypofractionated radiotherapy for early breast cancer.
Objectives
- To assess the tissue toxicity of hypo fractionated radiotherapy for early breast cancer.
- To assess the quality of life in patients on hypo fractionated radiotherapy for early breast cancer
- To assess the local recurrence of patients on hypo fractionated radiotherapy for early breast cancer.
Methods: 42 Patients with invasive early breast cancer who had underwent mastectomy or breast conservation surgery and who had indications for post op RT were subjected to a fractionation schedule of 40 Gy in 15 fractions to the chest wall or breast. Planning was done with conventional techniques. Tissue toxicity and quality of life of the patients were assessed during RT and on further follow up. Findings were graded using RTOG toxicity scale and EORTC questionnaire.
Results: Most of the patients were in the age group of 51-60 years, with 59.5% of patients in post menopausal group. All patients had grade 1 skin reaction. Two patients developed grade 2 skin reaction and one patient showed grade 4 reaction. Grade 1 mucositis, as throat pain was present in 76.2 % of patients. There were no grade 2, grade 3, or grade 4 mucositis. Grade1 lung toxicity was seen in 14.3% of patients during RT and 81% had moderate amount of arm edema during follow up. No patients had any cardiac or neurological symptoms and any local recurrence. Quality of life assessment showed worsening during RT which improved later on follow up. But shows decrease on comparison with pre RT status.
Conclusion: Adjuvant hypo fractionated radiotherapy after surgery to early breast cancer is generally well tolerated and is a viable alternative to the conventional fractionation with acceptable tissue toxicity, quality of life and local control. it provides a shorter treatment time and better patient compliance. This could prove especially useful in resource limited centres with high patient load.
Keywords: Hypofractionation – early-breast cancer – tissue toxicity – quality of life-local recurrence.
References
- Ferlay J, Shin HR, Bray F (2010) Cancer Incidence and Mortality Worldwide: IARCCancerBase No. 10
- Rangarajan B, Shet T, Wadasadawala T, Nair NS, Sairam R M, Hingmire SS, Bajpai J. Breast cancer: An overview of published Indian data. South Asian J cancer 2016;5:86-92
- Parkin DM: Global cancer statistics in the year 2000. Lancet Oncology 2001, 2:533-43.
- Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9(4):331–41.
- Timothy J. Whelan, B.M., Ch., Jean-Philippe Pignol, M.D., Mark N.et al, Long-Term Results of Hypo fractionated Radiation Therapy for Breast Cancer . N Engl J Med 2010;362:513-20.
- Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncology (R Coll Radiol) 2001; 13: 71–81.
- Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002; 94: 1143–50
- Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst1996; 88:1659-64.
- Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.;371(9618):1098–107.
- Whelan T, Pignol J, Julian J: Long-term Lancet 2008 results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer. Int J Radiat Onco Biol Phys2008; 72:S28.